Evolution of resistance of Klebsiella pneumoniae in Londrina University Hospital from 2000 to 2011

<span lang="EN-US">The present study aimed to evaluate the evolution of antibiotic resistance in clinical isolates of <em>Klebsiella pneumonia</em>e in the period of 2000 to 2011, at the University Hospital of Londrina (HU-UEL). A retrospective analysis of 2,318 antimicro...

Full description

Bibliographic Details
Main Authors: Diogo Jorge Rossi, Daniele Zendrini Rechenchoski, Ana Carolina Polano Vivan, Angélica Marim Lopes Dambrozio, Renata Perugini Biasi Garbin, Gerusa Luciana Gomes Magalhães, Regina Mariuza Borsato Quesada, Floristher Elaine Carrara Marroni, Marsileni Pelisson, Marcia Regina Eches Perugini, Eliana Carolina Vespero
Format: Article
Language:English
Published: Universidade Estadual de Londrina 2015-05-01
Series:Semina: Ciências Biológicas e da Saúde
Subjects:
Online Access:http://www.uel.br/revistas/uel/index.php/seminabio/article/view/19397
Description
Summary:<span lang="EN-US">The present study aimed to evaluate the evolution of antibiotic resistance in clinical isolates of <em>Klebsiella pneumonia</em>e in the period of 2000 to 2011, at the University Hospital of Londrina (HU-UEL). A retrospective analysis of 2,318 antimicrobial susceptibility tests of <em>K. pneumoniae</em> was performed from a database of the Clinical Laboratory of Microbiology of the University Hospital. In the period of 2000 to 2009, the main mechanism of resistance observed to ?-lactam antimicrobials was due to the production of ESBL ?-lactamase type (?-lactamase wide spectrum), which can be verified by the increased resistance of <em>K. pneumoniae</em> to 3rd generation cephalosporins and cefepime. However, the first strains of <em>K. pneumoniae</em> carbapenemase-producing appeared in 2009, compromising the efficacy of carbapenems. The rates of resistance to ertapenem ranged from 16%, in 2005, to 40% in 2011. Another class of committed antibiotics was the fluoroquinolones; for ciprofloxacin, resistance rates ranged from 13% to 62%, in 2001 and 2011, </span>respectively. Aminoglycosides exhibited oscillations of resistance during the period studied, reaching, in 2011, values of 56% and 30% for gentamicin and amikacin, respectively. Meanwhile, trimethoprim/ sulfamethoxazole and piperacillin/tazobactam reached about 60%, in the same period. Therefore, knowing the antimicrobial resistance of <em>K. pneumoniae</em> strains is essential for proper treatment of patients and adoption of appropriate measures that aims infection control, and proper use of these drugs.
ISSN:1676-5435
1679-0367